NCT00005639View on ClinicalTrials.gov

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

Azacitidine Injection

subcutaneous injection (SC)

DRUG

sodium phenylbutyrate

continuous intravenous (CIV)

Trial Locations (1)

21231

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00005639 - Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment | Biotech Hunter | Biotech Hunter